Foundational research by a City of Hope physician-scientist and his colleagues could one day help metastatic colorectal cancer patients decide whether to choose immunotherapy or chemotherapy as their first treatment option.
More From BioPortfolio on "Biomarker may help predict first treatment option for metastatic colorectal cancer patients"